Berberine in Bowel Health: Anti-Inflammatory and Gut Microbiota Modulatory Effects
International Journal of Molecular Sciences · 13.12.2025 · 26 (24) · 12021
DOI: 10.3390/ijms262412021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.12.2025. Verfasst von Anna Duda-Madej und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wroclaw, Poland. Hauptthemen laut MEDLINE: Berberine, Gastrointestinal Microbiome, Anti-Inflammatory Agents, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Disruption of the gut-microbiome-brain axis contributes to the development of chronic inflammation, impaired intestinal barrier integrity, and progressive tissue damage, ultimately reducing quality of life and increasing risk of comorbidities, including neurodegenerative diseases. Current therapies are often limited by adverse effects and insufficient long-term efficacy, highlighting the need for more comprehensive therapeutic approaches. Berberine (BRB), a plant-derived isoquinoline alkaloid, has attracted growing attention due to its pleiotropic immunomodulatory, neuroprotective, and gut-homeostasis-modulating properties, which involve reshaping the gut microbiota and underscore its therapeutic relevance within the gut–microbiome–brain axis. The aim of this review is to synthesize current scientific evidence regarding the anti-inflammatory mechanisms of BRB in inflammatory bowel disease (IBD). We compare its activity with first-line therapies and discuss its impact on microbial composition, including the bidirectional regulation of specific bacterial taxa relevant to intestinal and systemic disorders that originate in the gut. Furthermore, we emphasize that gut bacteria convert BRB into bioactive metabolites, contributing to its enhanced intraluminal activity despite its low systemic bioavailability. By integrating molecular and microbiological evidence, this review fills a critical knowledge gap regarding the comprehensive therapeutic potential of BRB as a promising candidate for future IBD interventions. The novelty of this work lies in unifying fragmented findings into a framework that explains how BRB acts simultaneously at the levels of host immunity, microbial ecology, and neuroimmune communication—thus offering a new conceptual model for its role within the gut–microbiome–brain axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wroclaw, Poland.
- Faculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wroclaw, Poland.
- Faculty of Biotechnology, University of Wroclaw, Fryderyka Joliot-Curie 14a, 50-137 Wroclaw, Poland.
ORCID-Profile: Anna Duda-Madej, Szymon Viscardi, Ewa Topola, Wiktoria Szewczyk, Przemysław Gagat
Förderung
- Wroclaw Medical University
Zitieren
APA
Duda-Madej, A., Viscardi, S., Łabaz, J. P., Topola, E., Szewczyk, W., & Gagat, P. (2025). Berberine in Bowel Health: Anti-Inflammatory and Gut Microbiota Modulatory Effects. International Journal of Molecular Sciences, 26(24), 12021. https://doi.org/10.3390/ijms262412021
Vancouver
Duda-Madej A, Viscardi S, Łabaz JP, Topola E, Szewczyk W, Gagat P. Berberine in Bowel Health: Anti-Inflammatory and Gut Microbiota Modulatory Effects. International Journal of Molecular Sciences. 2025;26(24):12021. doi:10.3390/ijms262412021
BibTeX
@article{DudaMadej2025,
author = {Duda-Madej, Anna and Viscardi, Szymon and Łabaz, Jakub Piotr and Topola, Ewa and Szewczyk, Wiktoria and Gagat, Przemysław},
title = {Berberine in Bowel Health: Anti-Inflammatory and Gut Microbiota Modulatory Effects},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {12021},
doi = {10.3390/ijms262412021}
}
EUVIMED